A mitochondrial antibody test is a blood test that looks for anti-mitochondrial antibodies, often called AMA. Clinicians most often use it when evaluating possible autoimmune liver disease, especially primary biliary cholangitis. A result is interpreted with liver enzymes, symptoms, other antibody tests, and sometimes imaging or specialist evaluation 1.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What is a mitochondrial antibody test?
A mitochondrial antibody test checks your blood for anti-mitochondrial antibodies, or AMA. These are immune proteins that can appear when the immune system reacts against parts of the body’s own cells 1.
The most important clinical link is primary biliary cholangitis, or PBC. This condition used to be called primary biliary cirrhosis, but the newer name is preferred because many people are found before cirrhosis develops 3.
Other names: AMA, anti-mitochondrial antibody, mitochondrial M2 antibody
You may see the test listed as AMA, anti-mitochondrial antibody, mitochondrial antibody, mitochondrial M2 antibody, or AMA-M2. AMA is the broader antibody test. AMA-M2 is a subtype often used because the M2 target is strongly linked with PBC 4.
What the blood test measures
The test does not look at your mitochondria directly. It looks for antibodies in the serum part of your blood. Labs may use methods such as indirect immunofluorescence assay, often shortened to IFA, or enzyme-linked immunosorbent assay, often called ELISA 4.
How this differs from mitochondrial DNA or genetic testing
AMA testing is an autoimmune liver test. It is different from mitochondrial genetic testing, which looks for changes in mitochondrial DNA or nuclear genes that affect mitochondria. If you are trying to understand the difference between regular DNA and mitochondrial DNA, our guide to DNA vs mitochondrial DNA explains the basics.
Why would a clinician order an anti-mitochondrial antibody test?
A clinician may order an anti-mitochondrial antibody test when liver blood tests suggest cholestasis, which means bile is not flowing normally. One key clue is an elevated alkaline phosphatase level, especially when it stays high over time 2.
- Abnormal liver tests, especially alkaline phosphatase, gamma-glutamyl transferase, bilirubin, or a broader liver function panel 5.
- Symptoms that can occur in PBC, such as fatigue, itching, jaundice, dark urine, dry eyes, or dry mouth 2.
- Evaluation for autoimmune liver disease, including PBC and sometimes autoimmune hepatitis overlap 3.
- Follow-up after a prior positive, borderline, or unclear antibody result.
Some people with early PBC have few or no symptoms. In those cases, the first clue may be a liver panel ordered for another reason 2.
What diseases are linked to anti-mitochondrial antibodies?
Anti-mitochondrial antibodies are most strongly linked to primary biliary cholangitis. In PBC, small bile ducts in the liver are injured over time, which can lead to cholestasis and liver scarring if the disease is not recognized and managed 2.
Guidelines describe AMA as a major part of PBC diagnosis when it appears with cholestatic liver tests, especially elevated alkaline phosphatase 3. PBC is autoimmune, meaning the immune system is involved. It is also associated with other autoimmune conditions, including Sjögren disease and thyroid disease 3.
AMA can sometimes be seen outside classic PBC, so the full clinical picture matters. Clinicians may consider autoimmune hepatitis, viral hepatitis, drug-related liver injury, biliary obstruction, or other causes of abnormal liver tests depending on the person’s history and lab pattern 5.
What does a positive mitochondrial antibody result mean?
A positive mitochondrial antibody result means the lab found AMA in your blood. It does not diagnose PBC by itself, but it can strongly support PBC when paired with a cholestatic liver test pattern, especially elevated alkaline phosphatase 3.
Positive versus high-titer results
Some labs report a titer, which is a dilution level showing how much antibody is still detectable. Other labs report units or a positive-negative result. Reference ranges, reporting units, and cutoffs vary by laboratory, so the original lab report matters 1.
A higher titer may make the result more convincing, but antibody level alone does not tell the whole story. Clinicians usually compare AMA with alkaline phosphatase, bilirubin, IgM, albumin, platelet count, symptoms, medicines, alcohol history, and imaging when needed 3.
When AMA-M2 may be used as a more specific follow-up test
AMA-M2 focuses on a specific mitochondrial antigen linked to PBC. Some clinicians use AMA-M2 when the broader AMA test is unclear, when the pattern does not fit, or when they want a more specific autoimmune liver marker 4. For a deeper look, see our guide to mitochondrial M2 antibody IgG.
What does a negative mitochondrial antibody result mean?
A negative mitochondrial antibody result means the lab did not find AMA above its cutoff. This can make PBC less likely, but it does not rule out every liver disease, autoimmune condition, or even every case of PBC 3.
A small group of people with PBC are AMA-negative. Guidelines note that PBC can still be considered when cholestatic liver tests and other PBC-specific antibodies or liver biopsy findings support it 3.
If symptoms or liver enzymes remain abnormal, clinicians may order other tests. These may include antinuclear antibody, anti-smooth muscle antibody, immunoglobulin levels, viral hepatitis tests, ultrasound, MRI-based bile duct imaging, or referral to a hepatologist 5.
How accurate is a mitochondrial antibody test?
The accuracy of an AMA test depends on the disease being evaluated and the lab method used. A meta-analysis found AMA had pooled sensitivity of about 84% and specificity of about 98% for PBC, while AMA-M2 had pooled sensitivity of about 89% and specificity of about 96%; these numbers are study averages, not a personal diagnosis 6.
Sensitivity means how often a test is positive in people who truly have the condition. Specificity means how often it is negative in people who do not have the condition. Even a strong test can have false positives and false negatives, especially when the pre-test chance of disease is low 6.
That is why clinicians do not read AMA in isolation. In PBC, guidelines use a combination of cholestatic liver tests, PBC-specific antibodies such as AMA, and sometimes liver biopsy if the diagnosis is still uncertain 3.
| Test or result | What it looks for | How clinicians use it |
|---|---|---|
| AMA | Anti-mitochondrial antibodies in blood | Supports PBC when liver tests show cholestasis 3 |
| AMA-M2 | A more specific M2 subtype of AMA | May help clarify suspected PBC or an unclear AMA result 4 |
| Alkaline phosphatase | A liver and bile duct enzyme pattern | Often the key abnormal liver test that prompts PBC evaluation 2 |
| Mitochondrial DNA testing | Inherited or acquired DNA changes | Used for suspected mitochondrial disease, not autoimmune liver antibodies |
Do you need to fast or prepare for the test?
For the AMA blood draw, fasting is usually not required for the antibody test itself. Still, follow the ordering lab’s instructions because other tests drawn at the same visit may have different rules 1.
- Bring a list of medicines and supplements, including hormone therapy, over-the-counter drugs, and herbal products.
- Tell the clinician about liver disease, autoimmune disease, pregnancy, heavy alcohol use, and recent infections.
- Ask whether other blood tests in the same order require fasting.
- Plan for a routine blood draw from a vein, often in the arm.
Blood draw risks are usually minor. MedlinePlus lists possible bruising, bleeding, soreness, infection, or feeling lightheaded after a blood test 1.
What other tests may be ordered with a mitochondrial antibody test?
A mitochondrial antibody test is usually part of a larger workup, not a stand-alone answer. Clinicians often pair it with liver enzymes, bilirubin, immunoglobulins, and other autoimmune markers to understand the pattern 5.
- Liver function panel, including alkaline phosphatase, AST, ALT, albumin, and sometimes gamma-glutamyl transferase 5.
- Bilirubin, cholesterol, and immunoglobulin M, often called IgM, because these can add context in suspected PBC 3.
- Antinuclear antibody, or ANA, and anti-smooth muscle antibody when autoimmune hepatitis or overlap disease is being considered 7.
- Ultrasound or MRI-based imaging if bile duct blockage, gallstones, or another structural cause needs to be checked 5.
- Referral to a liver specialist, called a hepatologist, when results are positive, unclear, or paired with ongoing abnormal liver tests.
How is this different from mitochondrial disease testing?
AMA testing looks for autoimmune antibodies. Mitochondrial disease testing looks for problems in how mitochondria work, often through genetic testing, enzyme studies, muscle biopsy in select cases, or other specialist testing 8.
This difference matters. A positive AMA does not mean you have poor mitochondrial energy, a longevity problem, or an inherited mitochondrial disorder. It most often points clinicians toward autoimmune liver evaluation, especially PBC 2.
If you are reading about mitochondria more broadly, our articles on mitochondrial DNA and disease and mitochondrial boosters cover different questions. Those topics are separate from AMA blood-test interpretation.
What should Chia readers know about this topic?
At Chia, this article is education-only. We do not currently offer mitochondrial antibody testing, AMA-M2 testing, liver imaging, or hepatology diagnosis through our catalog.
If your result is positive, negative, or borderline, the safest next step is to review it with the clinician who ordered the test or a qualified liver specialist. Bring the full report, not just the word “positive” or “negative,” because lab method, titer, reference range, and related liver tests all matter 1.
We also do not connect AMA results to longevity peptides, GLP-1 treatment, or general mitochondrial support unless a clinician has a clear medical reason. An AMA test is about autoimmune antibodies, not a measure of mitochondrial performance.
FAQ
AMA is the broader anti-mitochondrial antibody test. AMA-M2 looks for a specific M2 subtype that is closely linked with primary biliary cholangitis. Some labs or clinicians use AMA-M2 when they want a more specific follow-up test 4.
It can be important, but it is not a diagnosis by itself. A positive result may support primary biliary cholangitis when liver enzymes show cholestasis, especially elevated alkaline phosphatase. It should be reviewed with a clinician 3.
Yes, it is possible. Most people with primary biliary cholangitis have AMA, but some do not. If liver tests and symptoms still suggest bile duct disease, clinicians may order other antibodies, imaging, or specialist evaluation 3.
No. AMA testing does not measure mitochondrial energy production, cellular function, or longevity. It checks for autoimmune antibodies that are mainly used in liver-disease evaluation 2.
Ask the ordering clinician. A borderline result may be repeated or followed with AMA-M2, liver enzymes, IgM, ANA, anti-smooth muscle antibody, imaging, or referral, depending on the full clinical picture 1.
A primary care clinician may start the review, but many people with a positive AMA and abnormal liver tests are referred to a hepatologist, which is a liver specialist, or sometimes a gastroenterologist 5.
References
- 1.MedlinePlus. Antimitochondrial Antibody (AMA) Test. U.S. National Library of Medicine, 2024.
- 2.National Institute of Diabetes and Digestive and Kidney Diseases. Primary Biliary Cholangitis. National Institutes of Health, 2023.
- 3.Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 2019.
- 4.European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The Diagnosis and Management of Patients with Primary Biliary Cholangitis. Journal of Hepatology, 2017.
- 5.Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology, 2017.
- 6.Hu S, Zhao F, Wang Q, Chen WX. The Diagnostic Accuracy of Anti-Mitochondrial Antibody and Anti-Mitochondrial M2 Antibody for Primary Biliary Cholangitis: A Meta-Analysis. PLOS ONE, 2014.
- 7.Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology, 2020.
- 8.Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and Management of Mitochondrial Disease: A Consensus Statement from the Mitochondrial Medicine Society. Genetics in Medicine, 2015.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
